Company: BGLC
Filing Date: 2025-02-10
Form Type: PRE 14A
Source: 0001477932-25-000832
Chunk: 28

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-10
Form: PRE 14A
Chunk 28
---
COMMENDS A VOTE FORAPPROVAL OF THE ADJOURNMENT PROPOSAL AS DESCRIBED HEREIN.

| 18 |

<div align='center'>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</div>

The following table sets forth certain information known to us as of January 31, 2025 except where another date is noted below), with respect to beneficial ownership of our Common Stock by (i) each person (or group of affiliated persons) who is known by us to own beneficially more than five percent (5%) of our outstanding Common Stock, (ii) each director, (iii) each of our named executive officers (NEOs), and (iv) all current directors, executive officers and named executive officers as a group, together with the approximate percentages of outstanding Common Stock owned by each of them. The following table is based upon information supplied by directors, executive officers, other key executives identified as NEOs and principal stockholders. Beneficial ownership has been determined in accordance with Rule 13d-3 under the Exchange Act. A person has beneficial ownership of shares if the person has the power to vote or dispose of such shares. This power can be exclusive or shared, direct or indirect. In addition, a person is considered by SEC rules to beneficially own shares underlying options and convertible securities that are presently exercisable or convertible or will become exercisable or convertible within 60 days of the date that beneficial ownership is calculated. Unless otherwise indicated the address of each beneficial owner is c/o BioNexus Gene Lab Corp., Unit A-28-7, Tower A, Menara UOA Bangsar, No.5 Jln Bangsar Utama 1, 59000 Kuala Lumpur. The percentage of beneficial ownership is based on 17,667,663 shares of our Common Stock outstanding as of January 31, 2025.

| Name of beneficial owners                                   |     | Amount and nature of beneficial ownership of Common Stock |           |     | Approximate percentage of outstanding Common Stock (1) |      |   |
| Directors and Named Executive Officers:                     |     |                                                           |           |     |                                                        |      |   |
| Su-Leng Tan Lee                                             |     |                                                           |         - |     |                                                        |    - |   |
| Muhammad Azrul bin Abdul Hamid                              |     |                                                           |         - |     |                                                        |    - |   |
| Chee Keong Yap                                              |     |